Patient-Reported AutoImmunity Secondary to Cancer immunothErapy
NCT03849131
·
clinicaltrials.gov ↗
PHASE4
Phase
ACTIVE_NOT_RECRUITING
Status
905
Enrollment
OTHER
Sponsor class
Conditions
Opportunistic Autoimmune Diseases
Interventions
BIOLOGICAL:
Biological collection
Sponsor
University Hospital, Strasbourg, France